United States: DC Metro Area

Firms: litigation

Firms: prosecution

Firms: transactions

Adduci, Mastriani & Schaumberg, LLP

Adduci, Mastriani & Schaumberg sets the standard when it comes to International Trade Commission (ITC) patent litigation. The set’s unbeatable experience in Section 337 investigations gives it the most intricate knowledge of the ITC’s unique rules and procedures and an instinctual feel for the mindset of the commission’s administrative law judges. James Adduci II, Tom Schaumberg and Louis Mastriani are inspiring leaders of a firm that is excellent from top to bottom.

Arnold & Porter Kaye Scholer LLP

Arnold & Porter is among the busiest patent trial firms in the country and must be considered one of America’s patent litigation heavyweights; consequently, it makes its debut on the IAM Patent 1000 US national litigation table this year. It gets hired in big cases for all the usual reasons – a deep litigation bench being one – but also some that are less common; it isn’t a one-and-done firm that looks to turn a $10 million fee case into a $15 million fee case, but is very client and relationship focused. At the forefront of the practice is Matthew Wolf, who has been on an extraordinary run of late, most notably in prevailing over Edwards Lifesciences on behalf of Boston Scientific. “A terrific trial lawyer, Matt knows how to distil down complex issues and get right to the heart of a case. He’s brilliant on his feet in court and a superb team leader.” The prosecution practice is in a healthy groove too; there is price pressure from clients, of course, but the firm trains and retains talented young attorneys extremely well so that they can offer high-quality support at a lower billing rate. Life sciences connoisseur David Marsh is the set’s top patent procurement and strategic counselling guy. By getting the Food and Drug Administration (FDA) regulatory, litigation and prosecution groups all pulling in the same direction, he ensures prestigious patrons such as Monsanto a joined-up service. Arnold & Porter also channels its fine-grained IP and technology expertise into a vibrant transactional practice. Getting deals done and being pragmatic about the issues and risks clients are facing are what make “well-rounded commercial IP lawyer” Susan Hendrickson shine. She is an excellent choice for new-style collaborations driven by next-generation technology.

Baker & Hostetler LLP

BakerHostetler maintains a sizeable national patent practice with 170 lawyers in offices across the country; whether the firm has the capacity to undertake a piece of patent work is never a question that needs be asked. Many of its lawyers are multitalented and can cover a lot of ground for their clients, DC-based Kenneth Sheehan and Robert Hails being good examples. Primarily handling prosecution tasks, Sheehan thinks around the corner to potential licensing opportunities and litigation issues thanks to a broad non-contentious and contentious skill set; Hails has a combination of prosecution and litigation expertise that creates advantages for him in court and in the PTAB. The firm also has unique specialists on deck, such as government contracts connoisseur William Bergman. He is one of the few litigators with experience in district courts, the ITC, the Federal Circuit and the Court of Federal Claims.

Baker Botts LLP

Baker Botts has been performing at a consistently high level in ITC patent litigation and its market share of Section 337 investigations has grown dramatically. This is contributing to a near 100% utilisation rate of the associates in DC, making it a great place to be for up-and-coming talent and keeping ITC section leader Lisa Kattan in the limelight. The former senior investigative attorney at the ITC Office of Unfair Import Investigations has been applying her insider knowledge representing Fujifilm against Sony in a major multi-venue dispute. This is the sort of competitor battle that Baker Botts is well-suited to, given the incredible depth of its technical bench and excellent line-up of litigators. To give another similar example, the firm recently represented Western Digital and subsidiary SanDisk against IP licensor Pendrell in a matter that included a substantial ITC action, district court litigation in California and multiple PTAB challenges; here, Kattan joined with partners in Austin and Palo Alto to secure a satisfying settlement. Baker Botts also maintains an “excellent prosecution and counselling practice with sharp lawyers serving a very interesting and diverse client base”. An efficient manager of some large portfolios, Luke Pedersen is instrumental in the success of this. He is so much more than a prosecutor though, undertaking fascinating project-oriented transactional work to boot. He is representing Telesat in connection with joint development and manufacturing agreements pertaining to a state-of-the-art low-earth orbit satellite constellation set to launch in 2020. Coming full circle, Pedersen has also lately been involved in his first ITC complaint. In January 2019, the firm brought on board Michael Sartori from Venable. “He’s very consistent and has an excellent reputation among Japanese companies.”

Banner Witcoff 

Banner Witcoff is a major contributor to IP life in the United States and does much beyond the confines of its legal practice to help educate stakeholders in the IP market on the most important issues of the day; its WITCON programme for in-house counsel and DesignLaw programme, which brings together academics, product designers, USPTO representatives and lawyers, are good examples of this extracurricular engagement. The ensemble’s lawyers take this passion for all things intellectual property into their client practices, too, rendering a stellar service encompassing prosecution, post-grant proceedings and litigation. For their truly world-class designs offering, Robert Katz and Darrell G Mottley stand out from the crowd. They handle design prosecution work for Nike and Microsoft, both long-term clients. Frederic M Meeker and Ross A Dannenberg are their counterparts on the utility patent side. Of Meeker, a key relationship partner for major clients such as Comcast, one source comments: “I personally vetted Fred and picked him as our lead outside patent counsel some years ago, and it was one of the best decisions I ever made – he’s an exceptional lawyer and patent strategist. He is very responsive, open to constructive feedback, and hires and retains high-quality team members.” Computer scientist Dannenberg undertakes significant prosecution work for Citrix Systems, which is acknowledged to have one of the best portfolios of any software company in the country. The firm’s litigation practice got a shot in the arm in June 2018 when John R Hutchins came on board by way of Hunton Andrews Kurth. With his excellent technical credentials, he fit right in and has been doing sterling work as leader of several cases for Mattel.

Birch, Stewart, Kolasch & Birch, LLP

Falls Church, Virginia boutique Birch, Stewart, Kolasch & Birch is internationally endorsed for its patent prosecution proficiency. Deploying a well-rounded team of attorneys with impressive science and engineering backgrounds backed by finely tuned software and workflow systems, the firm procures all-weather-proof patents with a high degree of efficiency thanks to an intimate knowledge of the USPTO’s inner workings. Anchoring a high-calibre life sciences practice is MaryAnne Armstrong, who followed up her biochemistry PhD with a post-doctoral fellowship at the National Cancer Institute. She prosecutes with distinction and is hugely experienced as an opinion giver, strategic adviser and inter partes review counsel.

Blank Rome LLP

Intellectual property is something that Am Law 100 outfit Blank Rome takes seriously and the IAM Patent 1000 rankings attest to the versatility of its patent practice; representatives of the firm make the cut on each of the DC prosecution, litigation and transactions tables. Portfolio work in the high-tech domain is the forte of Stephen Soffen, a long-term strategic and commercial thinker whose protections are ironclad. One client comments: “Litigation is the true test of a good patent, as every flaw gets uncovered; on multiple occasions we have litigated patents that Stephen wrote, which verified that his claims were excellently written and sufficiently broad to be of commercial significance but not so broad that they wouldn’t hold up in court. Over the life of the patents in question, we realised hundreds of millions of dollars in royalties.” With ample litigation experience informing a far-sighted approach to prosecution and counselling mandates, James Brady acquits himself with similar distinction; the chemical and life sciences industries are his happy hunting grounds. Continuing the theme of broad-mindedness, IP and technology group co-chair Dipu Doshi has a deft touch on contentious and non-contentious matters, although his focus lies more towards litigation; he oversees important district court and PTAB campaigns for a global high-tech client base. Masterminding complex IP and technology deals is what Jon Grossman and Donald Gregory do best. Grossman is a software supremo who knows how to navigate subject-matter eligibility concerns; Gregory has coding, engineering, in-house patent counsel and abundant private practice experience on his résumé, which makes him incredibly well rounded as a deal broker and IP adviser.

Bookoff McAndrews PLLC

Celestial patent counselling and prosecution boutique Bookoff McAndrews ascends to the highly recommended tier in the 2019 IAM Patent 1000 – it is impossible to ignore the weight of positive reviews it garners year in, year out. “Its attorneys understand how to implement comprehensive and well-thought-out IP strategies and execute on delivering large and valuable portfolios. Working closely and effectively with inventors and chief technology officers, they prosecute patents that provide defensive postures for the long term; they also stake out offensive rights to future technologies that could be lucrative from a licensing perspective. They dedicate all the right resources to their clients and understand their innovations and businesses, which means you don’t have to constantly pay for attorneys to come up a steep learning curve.” One exciting piece of news to come out of the BoMc camp recently was the 1 January 2019 promotion of Kirsten Johnson to the partnership. She earned her PhD in physical chemistry at the Massachusetts Institute of Technology (under a Nobel laureate), setting the scene for a broad practice in the chemical, life sciences and energy industries, among others. Like her fellow partners, she is fiercely committed to quality in patent prosecution and has a lively strategic mind. She joins the firm’s other partners – Roland McAndrews, Les Bookoff, Dinesh Melwani and Christopher Agrawal – in the listings for the first time this year. “A rock star patent attorney, Roland knows the intricate details of the law and is an excellent strategist who ensures that optimum client-focused commercial outcomes are achieved.” “Les is a stellar attorney whose attention to detail is second to none.” “Dinesh is awesome – an energetic team leader who has helped to grow one of the more dynamic recent IP speciality firms.” Together, these three hold it down for Boston Scientific and have obtained over 500 patents for the medical device titan since 2012. Agrawal knows what it takes to drive IP value up and to the right. He has considerably amped up the firm’s computer and internet practice. A collaborative culture exists among them – even without a compensation scheme (which eschews origination fees) designed to encourage teamwork, these people would share as it is in their nature.

Buchanan Ingersoll & Rooney PC

Underscoring the A-to-Z nature of its patent capabilities, Buchanan Ingersoll & Rooney recently reorganised its IP section to create several new groups, including one each for post-grant proceedings, patent prosecution and IP litigation. In line with this, its leadership team has expanded, which was necessary in any case given the impressive growth of the overall practice. Taking charge with respect to PTAB proceedings, one of the most vibrant areas of activity, is Todd Walters, a post-issuance thought leader within the American Intellectual Property Law Association (AIPLA) and American Bar Association and a practice leader, too, with an excellent track record spanning more than 100 inter partes reviews and, going back, many interferences. Taking advantage of blended litigation and prosecution expertise, Erin Dunston is another ace up the firm’s sleeve when it’s time to roll at the PTAB. She handles a burgeoning docket of life sciences inter partes reviews. Prosecution, however, remains the cornerstone of Buchanan’s IP practice and leading on this now is international mechanical maven William Rowland. Keeping the organisation ahead of the curve in terms of automation and process streamlining is one of his tasks, and he’s doing a top job of it. Other rock-solid patent prosecutors and portfolio managers include Robert Mukai, who is intimate with the chemical industry, and Charles Wieland III, who is at his best in high-technology areas such as software and e-commerce. Coming in for particular praise this year, Wieland “does excellent work generating uniformly high-quality patents from invention disclosures of varying quality. His efforts to create valuable patents are tireless”. Helming the litigation practice, meanwhile, is Lloyd Smith, whose recent work for Concordia Pharmaceuticals – including a finding of wilful infringement against defendant Method Pharmaceuticals plus treble damages – showcases the firm’s effective commingling of IP and FDA regulatory expertise. Matthew Fedowitz, who previously worked in the FDA’s Office of Generic Drugs, has been operating at a high level in pharmaceutical disputes, too, solving multifaceted problems with a commercial touch. Best described as a global patent strategist, executive shareholder Patrick Keane watches over all aspects of the practice to ensure they remain in keeping with domestic and international policy trends and developments.

Cooley LLP

Cooley operates at the cutting edge of the high-tech and life sciences domains and maintains full-bodied coast-to-coast prosecution, litigation and transactional practices in each; such litheness makes it one of the best one-stop shops for innovators in the entire country. Microcosmic of the firmwide practice, the crew in Reston – Erik Milch, Scott Talbot and Frank Pietrantonio – handles the full spectrum of contentious and non-contentious matters with alacrity. Milch’s experience procuring, monetising and fighting over patents gives him a 360-degree strategic understanding of the tasks and thorny problems that clients send his way. It’s the same for technology aesthete Talbot, whose well-founded counsel inspires confidence in some of the medical technology field’s most dynamic players. Recommended for litigation, Pietrantonio is in his element litigating sprawling multi-forum battles. By contrast, around the negotiation table is where Adam Ruttenberg likes to be. The DC-based lawyer gets signatures on the dotted line of lucrative technology deals with the minimum of fuss.

Covington & Burling LLP

“Eminently capable in the life sciences, Covington has a really deep bench of top-notch patent lawyers and a tremendous FDA practice to support them.” “Well known and respected on the branded side of the industry, Christopher Sipes is on the frontlines of most of Covington’s major pharmaceutical litigations; he is really smart, takes a reasonable approach and has first-rate regulatory knowledge.” Einar Stole and Kevin Collins also draw praise, Stole for being “an extremely creative advocate and gentleman litigator who doesn’t engage in gamesmanship” and Collins for “doing beautiful work through all phases of patent litigation, including trial, and not just parachuting in”. With a biochemistry PhD and ample prosecution experience, Stole has match-winning technical credentials, too. While the litigators write the headlines, chair of the practice John Hurvitz quietly rewrites the rules of the industry by shepherding transformative deals and collaborations to a successful close. The high-tech practice mirrors many of the features of the life sciences practice and includes top litigators – Richard Rainey comes immediately to mind – and transactional lawyers such as Stuart Irvin. In-house experience serving as GE’s global IP litigation head has taught Rainey that clients are much more interested in business resolutions than courtroom fireworks, though sometimes the latter creates opportunities for the former. Irvin has a gift for settlement transactions and IP and technology-driven deals of all kinds. Working across all technical areas, eminent American College of Trial Lawyers fellow George Pappas continues to lead vital cases in which only a win will do. Another jewel in Covington’s crown is the ITC practice manned by Sturgis Sobin, a veteran of 25 IP trials at the commission, and Alexander Chinoy, whose broad trade litigation expertise is a real boon.

Dentons US LLP

A national and worldwide force dispensing a wraparound patent prosecution, litigation and transactional service, Dentons is a natural choice for elite innovators in the life sciences and technology industries. Chair of the global IP and technology group, and a member of the firm’s global board, Song Jung is an inspirational leader for his colleagues and his clients. Recommended by the IAM Patent 1000 in all three core areas of patent practice, he is as versatile as they come and well positioned to guide clients strategically so they can take advantage of the best that Dentons has to offer. If it’s litigation, that might mean getting Mark Hogge involved. “He acts with exceptional perspicacity and his resolve is never broken, no matter what tactics difficult opponents engage in.” “Mark is an outstanding IP lawyer who is supremely skilled in all phases of IP litigation and an excellent strategist adept at executing budget-efficient solutions that achieve business goals.” If, on the other hand, clients are looking to protect innovations and cultivate commercially valuable portfolios, Martin Bruehs, Eric Sophir and Mark Kresloff all fit the bill perfectly. Head of the chemical practice Bruehs is “best in class in terms of his legal and technical prowess, but moreover someone with an exceptional understanding of business”. “Martin works extremely hard to meet tight deadlines and always finds ways to add value. Communications with him are always smooth and he frequently travels internationally for face-to-face meetings.” Like Bruehs, though in cutting-edge high-tech areas, Sophir goes above and beyond his prosecution briefs to deliver incisive white-space analyses to clients. Internationally experienced Kresloff is a thought and practice leader in the telecoms and standards area, as well as in medical devices. His litigation experience informs a forward-thinking approach to prosecution tasks.

DLA Piper LLP (US)

With its well-rounded US patent practice, DLA Piper is an effective one-stop shop for innovators protecting and enforcing patent rights across the country; its global support package is also value additive for clients, many of whom are international sector leaders. For robust, broad-scope patent protections in the electronics and computer technology spaces, Dale Lazar and former radar engineer Gianni Minutolio in Northern Virginia are the lawyers to call. James Heintz and Joseph Lavelle are their counterparts on the contentious side. Heintz is among the most technically savvy patent litigators around thanks to years of prosecution experience; Lavelle is hailed for his narrative skills and polished courtroom presentation.

Drinker Biddle & Reath LLP

Life sciences companies, be they large or small, make a beeline to Drinker Biddle because of Mercedes Meyer, a charismatic biotechnologist whose authority on subjects such as patent eligibility and ethics elevates her above 99% of patent prosecutors. She supervises the global development of valuable patent portfolios that make her clients hot targets for investment and collaborations. The presence of Robert Stoll is also an excellent reason to call on Drinker Biddle. He served as commissioner for patents prior to joining the firm and knows the USPTO better than practically all other private practice lawyers. He is a discerning choice for far-reaching IP counsel.

Fiala & Weaver PLLC

This growing but streamlined boutique “focuses on – and delivers – top-quality, efficient prosecution”. “Its attorneys are technically highly skilled and can get up to speed rapidly on new technology areas; they are also very proactive in learning about your business and adjusting their approach to meet your needs as a client. They interact well with inventors and conduct frequent interviews with examiners to ensure things get done properly.” All of this serves to trim the prosecution timeline – after all, patent rights have become more speculative meaning companies want to invest less in each case and get a quicker result. This approach and setup as a virtual firm backed by sophisticated IT tools and systems make Fiala & Weaver a fantastic value proposition. Shining on complex software and circuit matters are nimble prosecutors Thomas Fiala and Jeffrey Weaver.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

“Nationwide, Finnegan is certainly in the top tier of patent prosecution firms.” The statistics bear this out – Finnegan marshals a group of 230-plus USPTO-registered professionals (including many former examiners) and files in the region of 3,000 US and 1,500 foreign patent applications each year. Top lawyers Adriana Burgy, Mark Sweet, Gregory Gramenopoulos and Elizabeth Ferrill ensure that these efforts are successful while bringing a whole lot more to the table: Burgy captains the patent office practice and leads the way on the patenting of cutting-edge life sciences technologies, leveraging litigation experience to maximise long-term protections; a cleantech authority, Sweet manages NanoFlex Power Corporation’s worldwide organic photovoltaic device patent portfolio, making excellent use of his carefully cultivated global network to get the best for the company; Gramenopoulos also plays on the global stage and serves up perspicacious strategic prosecution and licensing counsel to many European and other high-tech clients; Ferrill is “an undisputed expert on design patents who enlightens others with her deep and constantly up-to-date knowledge” and, together with Gramenopoulos, represents Google with respect to its graphical user interfaces and icons. Looking at Finnegan through the prism of its litigation practice, sources confide that “there is a huge amount of talent within the firm” – something the IAM Patent 1000 pays testament to with its long list of recommendations. One of the line-up’s most famous representatives is “wonderful lawyer” Charles Lipsey, “an excellent lead in big pharmaceutical cases” and “formidable opponent but also a gentleman who plays by the rules”. AstraZeneca and Eli Lilly rely on him for results in Hatch-Waxman Act litigation. Helping to make Finnegan a redoubtable force in pharmaceutical and biotechnology cases are James Monroe, Sanya Sukduang, Bryan Diner and Michael Flibbert. Biogen’s man Monroe serves as chair of the firm and a member of its management committee; Sukduang is a “proactive lawyer who thinks outside the box”, making him “an excellent strategic sounding board”; Diner’s combination of litigation and prosecution smarts and knowledge of the European patent system sets him apart; making his debut in the guide this year, Flibbert has been fending off inter partes review petitions filed by biosimilar drug makers with a striking rate of success acting on behalf of AbbVie Biotechnology. Similar depth can be seen on the computer technology and telecommunications side of the practice, which is anchored by Doris Johnson Hines, Jeffrey Berkowitz and Yanbin Xu. In her contentious practice Hines regularly showcases her deep licensing and patent monetisation expertise and has recently been representing Toshiba America Information Systems in a breach of contract action against MPEG LA; Reston managing partner Berkowitz has been in the limelight litigating for FedEx against Ronald A Katz and Intellectual Ventures; and Xu advises Xiaomi on a host of US patent issues. Worthy of special mention are Finnegan’s appellate and PTAB practices, the quality of which serves to elevate the firm’s overall litigation offering above those of its competitors. Wizards at the Federal Circuit include James Barney, a “long-term strategic thinker who takes away a lot of the squabbling and pettiness in litigation”, “spectacular lawyer” Michael Jakes and IP Hall of Fame member Donald Dunner. One of, if not the best post-grant practitioner in the country, Erika Harmon Arner continues to garner loud applause from the market as an “incredibly creative, thoughtful and goal-oriented” lawyer. Hailed as “an icon in the patent space” and a “post-issuance thought leader”, Thomas Irving “can have a roomful of 100 patent lawyers in front of him and get them all engaged in less than 30 seconds”. “He’s a powerhouse when it comes to patent strategy.” To complete the litigation picture, Smith Brittingham deserves credit for his ITC work on behalf of companies such as Toyota. Anticipating clients’ problems and understanding their business objectives, the transactions team of Brian Kacedon, John Paul and William Pratt makes Finnegan a top name in the commercial IP space. “An outstanding writer and tactician with excellent instincts, Brian is one of the leading experts on patent licensing in the entire life sciences industry, as well as a skilled and experienced patent litigator. He knows how his clients like to operate and tailors his work product accordingly; on a personal level, he is an incredibly friendly and reasonable individual who is a pleasure to work with.” A board member of the Licensing Executives Society International, Paul is another top licensing authority. IP monetisation and government contracting are Pratt’s areas of specialisation.

Fisch Sigler LLP

Fisch Sigler takes a rigorously commercial approach to patent litigation – it focuses on the most efficient way to bring about outcomes that make or save clients money and align with their broader business objectives. This often means having cases quickly dismissed, leaving plaintiffs with nothing; Amazon.com and Juniper Networks are recent beneficiaries of the set’s no-nonsense approach. Should a case go to trial, technology industry leaders are also in excellent hands; Alan Fisch knows how to win in even the most hostile environments – just check out his defence record in the Eastern District of Texas. He can back up any trial win at the appellate level, too.

Fish & Richardson

Drawing iron strength from their interconnectedness, Fish maintains market-leading practices in patent prosecution, litigation and post-grant proceedings. A tremendous year on the prosecution front has seen the firm make significant inroads in Asian markets; its ability to do US and European work – via its busy Munich office – makes it very appealing to Chinese companies in particular. Already fully paperless and with sophisticated docketing tools, Fish is also stepping up its effort to source and develop AI solutions to further streamline its practice. At the forefront of these international and technical initiatives is John Hayden, who provides inspiring leadership as head of a nearly 200-strong patent group. Key members of this in DC include David Jordan and Phyllis Kristal. Jordan is a software maven who has secured 500-plus patents for clients since the Alice decision. “You can tell how knowledgeable and experienced he is from the way he looks at issues deep below the surface.” Kristal has a mechanical engineering background but her technical range is virtually unlimited – this sits well with her panoramic perspective on patent issues, encompassing procurement, infringement and monetisation. If you’re wondering why top innovators consistently turn to Fish for major pieces of competitor patent litigation, the firm’s incredible DC trial bench provides more than a clue. Ruffin Cordell is “extremely good on his feet and a top IP trial lawyer”. “He is hard working, engaging and articulate, and fantastic at managing the strategic aspects of his cases.” “Michael McKeon and Christian Chu make a great pairing – Mike is brilliant in court while Christian has an excellent technical brain.” Speaking of dynamic duos, Indranil Mukerji has recently linked up with Silicon Valley lawyer Jonathan Lamberson on cases for Microsoft. Mukerji’s tenacity and pragmatism have made disciples of many top technology companies. Making important contributions to Fish’s success in life sciences litigations – as well as in medical devices and electrical cases – is Ahmed Davis, who debuts in the IAM Patent 1000 this year. He is integral to broader firm life, too, being a member of the management committee and diversity leader. Leading the way in Section 337 ITC investigations, Joseph Colaianni is “an excellent advocate, effective trial lawyer and trusted colleague”. Crucially, Fish can back up its trial victories at the Federal Circuit thanks to appellate specialist Lauren Degnan. As the most active firm at the PTAB – by a not-insignificant margin – Fish knows what it takes to win patent disputes in all forums. The set’s “post-grant thought-leader” Karl Renner is a big-picture strategic thinker who is fair-minded and critical of his own work. The environment he has created is very supportive of younger attorneys like David Holt, who has flourished by taking advantage of the leadership opportunities that have come his way. Holt recently managed five cases for Bose Corporation, pursuing an aggressive defensive strategy to deny Freebit’s institution of inter partes reviews. The post-grant team draws judiciously on the skill sets of other patent divisions to secure the best results; as an inter partes and covered business method review specialist with extensive prosecution and litigation experience, Timothy Riffe helps to make this happen.

Foley & Lardner LLP

Foley & Lardner maintains robust prosecution, litigation and transactions practices and fosters a culture of cooperation and collaboration between them; it is, then, a choice destination for one-stop shopping and holistic patent counsel. The post-grant area of activity is one of the buzziest for the ensemble, with excellent leadership being shown by head of patent office trials George Quillin, who most notably successfully represented Greene’s Energy against Oil States Energy Services in the famous 2018 case concerning the constitutionality of the inter partes review process. The increasing use of such proceedings by traditional pharmaceutical clients has also brought Stephen Maebius to the fore of the post-issuance space, and has enhanced the strategic counselling aspect of Courtenay Brinckerhoff’s practice. Brinckerhoff edits the firm’s PharmaPatentsBlog and is hailed as one of the life sciences sector’s guiding lights; biotechnology patrons struggling with patent eligibility issues, for example, find her to be an invaluable reference. As an influential patent prosecutor, she gets USPTO examiners proactively finding ways to resolve problematic issues faced by the industry. In the office next door to hers is Michele Simkin, who runs a vibrant international counselling practice for established and start-up pharmaceutical and biotechnology companies as well as academic institutions. As a lawyer she understands her clients’ needs and strategic goals while, as chair of the IP group, she knows how to effectively deploy resources. Foley’s practice in the electronics and automotive industries is also vigorous and here litigation and licensing counsel Pavan Agarwal stands tall in DC. He is a leader on a multi-office team tailored to represent longstanding client Broadcom.

Gibson Dunn & Crutcher LLP

“Gibson Dunn’s patent litigators are in court a lot and their experience really shows – they are just excellent on their feet; formidable all round, their written work product is also first-rate.” A more-than-reliable representative when whole businesses are on the line, Brian Buroker handles difficult opponents, intricate technologies and complex fact patterns with consummate elegance. A “top-flight lawyer and strategic thinker who always finds ways to add value”, Mark Perry anchors a “wonderful appellate practice” at the firm.

Goodwin Procter LLP

Goodwin’s team in DC just keeps getting better and stronger; in June 2018 it acquired an athletic ITC and district court litigation unit from Greenberg Traurig made up by Mark Davis, Ronald Pabis, Stephen Shahida and Patrick McCarthy. The move gives it a potent high-technology trial capability that will sit nicely next to the sterling life sciences litigation practice run by Washington DC head of intellectual property William James. The “top litigator” continues to reap excellent reviews from leading pharmaceutical companies, with one commenting: “Bill has developed a reputation as one of the pre-eminent patent litigators in the country and is the person we go to on our most important and high-stakes cases. He has an exceptional ability to cross-examine world-renowned testifying experts and can create a good rapport with judges instantaneously. He understands the pharmaceutical industry and how it works, demonstrates excellent judgement at all times and is extremely client oriented.” Carrying on the fight at the Federal Circuit for the firm’s prestigious pharmaceutical patrons, William Jay is a “really impressive appellate star”. Showcasing his flawless brief-writing skills, he recently emerged victorious from a hard and long-fought dispute between his client Actavis and Bayer Healthcare Pharmaceuticals, reversing a Delaware district court decision by Judge Gregory M Sleet that upheld the validity of an orally disintegrating tablet patent owned by Bayer. Well-positioned across all forums, Goodwin is not to be overlooked for post-issuance instructions. Coming from an electrical engineering background and possessing well-rounded prosecution and litigation capabilities, Stephen Schreiner has the toolkit to succeed at the PTAB. With the results of several inter partes reviews urgent in the context of an important battle with Amazon.com, Personalized Media Communications recently turned to him.

Harrity & Harrity LLP 

Fully deserving its promotion to the IAM Patent 1000 highly recommended tier for prosecution, “Harrity & Harrity is a top performer in the patent field. It ensures consistent high quality by performing legitimate second-attorney reviews on every patent application and does this without ever missing a deadline. Its attorneys conduct structured and methodical inventor interviews and obtain full and complete disclosures before drafting; they also proactively interview examiners in connection with almost every office action and these interactions significantly reduce the amount of written material in the file history, which not only shortens the prosecution process but produces stronger patents. When it comes to foreign prosecution, they give concise and well-reasoned recommendations on how best to proceed. They also excel at competitive analytics and provide results quickly and in clear and easy-to-understand formats. The firm doesn’t have a weakness.” “John Harrity undertakes top-quality prosecution with an eye towards creating commercially useful assets in a timely manner. Inventors love working with him because he understands them and writes in a way that saves them time in terms of review. He is also current with all relevant changes in US patent practice.” “Paul Harrity is extremely process oriented and has amazing attention to detail. He is doing a lot of interesting things in the practice – tracking examiner trends, for example – and the work he does helps his clients make the best decisions possible.” The two brothers have the firm way ahead of the curve when it comes to the development of disruptive technology for the patent field; their software development team has stepped up its efforts around machine learning prediction models and process efficiency, so watch this space.

Hunton Andrews Kurth LLP

The April 2018 merger between Andrews Kurth Kenyon and Hunton & Williams created a firm with over 70 IP lawyers – nearly all of whom have technical degrees – in offices throughout the country. DC is home to two of the set’s best prosecutors, Shawn O’Dowd and Daniel Shanley; together they represent a slew of marquee names including Toyota, NICHIA and Cadence Design Systems with respect to US prosecution and strategic portfolio development. They like to be hands-on and get close with inventors and examiners to ensure maximum protection.

Jones Day

A global law firm geared up to meet the demands of Fortune 500 companies, Jones Day is richly resourced in terms of patent and technology expertise. Defending its clients and enforcing their rights in litigation are particular strong suits of the firm’s DC attorneys, who collectively cover all forums: Blaney Harper co-leads the ITC practice and is also hugely experienced in district courts; Gregory Castanias is an “accomplished general appellate and Supreme Court advocate with a deep knowledge of patent law”; and Douglas Pearson is a doctor of applied physics with a dynamic PTAB practice.

Jones Robb PLLC

Growth for patent boutique Jones Robb has occurred by way of an increasing flow of instructions from existing clients; the firm’s time and cost-efficient delivery of a high-quality and customised work product is engendering strong loyalty in the scientific and engineering communities. Prosecution forms the bedrock of the practice and, at the USPTO, “the firm more than occasionally performs miracles”. “With its close ties with the examiner corps, sure touch in interviews and ability to overcome 101 rejections, it is a go-to for consistent success in getting applications over the finish line.” Beyond filing, the set offers an appealing list of additional services, from competitor monitoring to white-space analysis to IP licensing, making it a vital strategic ally all around. Setting the tone of excellence are Susanne Jones and Kevin Robb. Jones manages global portfolios deftly and is increasingly sought after for opinions; her focused industries include medical devices, life sciences and energy. Original drafting of patents in the high-technology domain is Robb’s metier.

Kirkland & Ellis LLP 

Kirkland & Ellis’s sizeable set of high-calibre trial lawyers form a powerful strike force for prestigious clients; rigorously commercial, creative and tenacious, they routinely field the most challenging litigation instructions, which keeps them on the bleeding edge of modern IP development. For example, gold-rated trial lawyer Gregg LoCascio and appellate ace John O’Quinn recently took their long-running fight for Schlumberger and subsidiary WesternGeco against ION Geophysical regarding remote-sensing deepwater oil and gas exploration technology to the Supreme Court, which found that the Federal Circuit improperly overturned the lost profit damages WesternGeco scored in a 2012 jury trial; this sets a precedent regarding the potential for recovering lost profit damages for injury caused outside the United States due to acts of infringement inside the United States. ITC patent litigation is one of the firm’s strong suits, which is unsurprising given the speed and intensity of Section 337 investigations. Alongside LoCascio, Paul Brinkman is another heavy-hitter at the commission. Flexing a near blemish-free ITC trial record, he has deep trade law expertise which distinguishes him from other patent lawyers. Edward Donovan has won and beaten exclusion orders at the ITC but is best known for embodying another of the firm’s unique selling points – expertise in SEP matters.

Latham & Watkins LLP

In heavy-duty patent litigation, “Latham & Watkins is brilliant at identifying the best strategy early, pursuing it diligently and staying on top of absolutely everything – its lawyers never miss an opportunity to do damage to the other side”. There are many “excellent tacticians” on deck in DC and in other offices, which is why the firm is perennially selected for the IAM Patent 1000 litigation gold tier at both a local and national level. In hotly contentious life sciences disputes, Michael Morin and David Frazier can be relied on to deliver a resonant performance and a satisfying result. “Michael maintains excellent command of his team and has real presence in the courtroom.” He also “does a terrific job of breaking down the technology”, as does Frazier, who sports a Harvard PhD in microbiology and molecular genetics. Forming a dream team on the high-tech side are Maximilian Grant, an inspirational trial team leader; Matthew Moore, who “knows how to prove the most creative defensive theories”; and Lawrence Gotts, who has litigated in many forums including, uncommonly, the Court of Federal Claims. Many of these lawyers do tremendous work in the ITC, though top honours there belong to Bert Reiser. “Bert is a former ITC staffer who has navigated some very difficult cases successfully. He is knowledgeable about every aspect of trial work and has an excellent understanding of what motivates different personalities.” Latham’s talent acquisition efforts have gone extremely well lately; a veteran of many investigations, Jamie Underwood bolstered the ITC practice further when she joined from Alston & Bird in February 2018; “fabulously strategic litigator” Tara Elliott then made the switch from WilmerHale in May. Other newsworthy developments include increasing strength in PTAB litigation, which is the preserve of Robert Steinberg.

Mayer Brown

A highpoint in 2018 for Mayer Brown’s patent team were two major victories scored for Japanese consumer electronics company Maxell against ZTE; in the first of these, the team earned a verdict of infringement of all seven patents in suit and an award of $43.3 million in damages after a 10-day jury trial in the Eastern District of Texas; the team then persuaded the PTAB to deny institution of seven inter partes reviews by highlighting claim construction and other problems in ZTE’s petitions. Masterminding this was Jamie Beaber, an indefatigable trial lawyer who demonstrates a level of commitment that is second to none. He is also a highly motivational team leader – a testament to his success in this regard are the regular partner promotions from his crew, which number three in three years. He makes sure that the best-suited people are put on each task – this benefits his juniors, who rapidly gain experience, and his clients, who get better and more cost-effective all-round representation. Sharing this mentality is the dynamic Alan Grimaldi, a luminary with decades of experience going through trial. A perfect strategic sounding board, he worked with Beaber on the Maxell case. Gary Hnath delivered another jury trial win in a tough case acting for Zhejiang Medicine Co and ZMC-USA in a patent dispute regarding CoQ10, a top dietary supplement; the client was found not to have infringed a competitor’s patent. Chiefly as a result of his ITC dexterity, Hnath has formed strong links with many Chinese companies. Also accustomed to winning ways is Stephen Baskin, the DC IP practice leader; though appeals and counterclaims are ongoing, he recently got a complete victory on non-infringement for NCR Corporation in a knotty dispute concerning ATM technology.

McDermott Will & Emery

Representing hundreds of sophisticated life sciences and high-technology patrons and fielding a deep 100-plus team, including many USPTO-registered attorneys (and former examiners), McDermott Will & Emery can be all things to all innovators. The DC office is an epicentre of the group in terms of trial expertise, with Nicole Jantzi, Paul Schoenhard, Jay Reiziss and Thomas Steindler all coming in for vociferous praise: “Nicole and Paul demonstrate significant technical expertise regarding complex electrical and mechanical engineering and design concepts, and convey clear explanations of them in the courtroom. They are superb, creative and aggressive litigators who inspire high confidence without ever overselling the legal merits of a dispute.” The firm chose well when it recently appointed her to head the global IP group: “With respect to leadership, Nicole has a remarkable ability to gather and lead a team, and masterfully deploys other partners, associates and staff in a very efficient way that maximises the value of their work while saving the client unnecessary fees.” “Jay thinks strategically and tactically about litigation and is a fabulous, thorough and knowledgeable lawyer who gives rock-solid advice on complex issues. He understands both law and business.” Though best known as an ITC supremo, Reiziss handles district court litigation and appellate matters with aplomb, as a recent win establishing new venue law shows: acting for ZTE, he challenged venue by filing a motion to dismiss a claim brought by American GNC Corporation in the Eastern District of Texas; this motion was denied by the court because ZTE failed to meet the burden of proof it bore; following two rounds of briefing on mandamus at the Federal Circuit, this was reversed, establishing that Federal Circuit law should govern the burden of proving venue in patent cases. Steindler, who heads the IP litigation practice, is one of the firm’s top pharmaceutical trial lawyers. “He takes an innovative approach to litigation strategy and is tenacious and aggressive, but at the same time a reasonable negotiator with opposing counsel. Always mindful of his clients’ business goals, he is a valuable and level-headed resource in brand-side abbreviated new drug application (ANDA) litigation and can be counted on to do an outstanding job.” Flying the flag for McDermott’s prosecution practice in DC is Michael Fogarty, an instrument of patent procurement and portfolio management success for Panasonic and Taiwan Semiconductor Manufacturing Company.

Morgan Lewis & Bockius LLP

Already credentialed as one of the country’s leading full-service patent firms – with excellent prosecution, litigation, post-grant and transactional capabilities – Morgan Lewis has taken things to the next level and orchestrated huge expansion in the past year; in July and August 2018, it took on a total of 16 partners from McDermott Will & Emery for its Chicago, DC, San Francisco, Silicon Valley and Orange County offices. It then made further moves at the start of 2019, unveiling fellow former McDermott partner Hosang Lee as its new signing in DC. Highly proficient at helping Korean and other Asian clients navigate the US patent landscape, Lee has a broad prosecution, licensing and litigation skill set that will help him integrate quickly in his new environment. Staying on the prosecution side of things, another name to note in the US capital is Robert Smyth, one of the main engines of the firm’s rich life sciences practice. Managing worldwide patent portfolios for Merck & Co, Acerta Pharma and more, his practice is impressively international in scope; his expertise on post-grant and opposition proceedings in many jurisdictions is a major boon to his clients. Keeping the set’s ITC practice in fine fettle, meanwhile, Eric Namrow has the organisational, leadership and trial skills to see sprawling multi-patent ITC campaigns to a successful close. He is a big believer in teamwork and collaboration, and quickly gets the whole firm pulling in his clients’ direction.

Morris Manning & Martin LLP

Patent prosecution and strategic portfolio development in the biotechnology theatre are the trump cards of Morris Manning & Martin. Its resolutely commercial team has the key to unlock the full potential of IP assets, making it the darling of dynamic small to mid-sized companies. Charismatic practitioner Ping Wang is the individual many come to see: “Her in-depth understanding of the patent process in the United States and around the world is critical to ensuring you get maximum value from your prosecution. It is always amazing how you can give Ping a simple idea and she will turn it into a very impressive patent document, much of the value of which is based on her creativity and experience.” One source comments: “Ping is incredibly efficient and responsive, and unbelievably good when it comes to strategy – I would not trade her for anyone!” Another adds: “It is remotely possible that there is a better patent lawyer somewhere out there, but I cannot imagine what they could provide that Dr Wang has failed to provide.” Also operating at a high level is Michael Ye. “Should investors scrutinise the patents that Michael obtains, they will invariably be satisfied with the high level of protection they afford. An insightful lawyer with a rich comprehension of science, he is dedicated to producing the highest-quality work product possible – working day and night, he does whatever is needed to get the job done.”

Morrison & Foerster LLP

Morrison & Foerster is not a firm to be trifled with at the ITC. “A leader in the ITC Trial Lawyers Association”, Brian Busey is an “effective litigator with a keen strategic mind as well as a great scholar and true gentleman”. His colleague Lynn Levine is, no less, the former director of the ITC’s Office of Unfair Import Investigations. As such, “she is a true insider who knows the history of the commission and the personalities of the decision makers there”. The top technology and patent litigation firm’s DC office is also home to one of the leading Supreme Court lawyers in the land, Deanne Maynard. She is a pathfinder in many legal disciplines including intellectual property, as her recent work on biosimilar pharmaceutical litigation clearly shows.

Oblon 

Oblon obtains more US utility patents than any other firm year in, year out and – by combining high-efficiency and smart, analytic approaches – it keeps costs to a minimum while delivering on quality. Doing well to maintain its status as a top prosecution outfit is managing partner Philippe Signore. The diversity of his practice in the prosecution, litigation, post-grant, counselling and designs areas, coupled with the international nature of it, has cultivated in him a broad and refined strategic IP sense. Contrasting with physics PhD Signore from a technical perspective, but otherwise similar in terms of perspicacity and worldliness, is fluent Russian speaker Marina Miller, a molecular biologist and anchor of the life sciences practice. She represents the Human Stem Cell Institute and NextGen Healthcare on all IP issues arising from the product development process; helping the same with licensing matters is chair of transactions and organic chemistry PhD Derek Mason. Though hit by recent departures, the firm’s PTAB group remains a healthy one. In charge of the post-grant section, recent AIPLA board member Todd Baker is an experienced prosecutor in the electrical and mechanical arts who has guided clients to victory in many inter partes and covered business method reviews. Important contributions to the practice also come from Vince Shier, a chemical pro and repository of trust for life sciences entities looking to procure, defend and enforce patent rights. With Robert Mattson and Eric Schweibenz leading the charge, litigation in district courts and at the ITC has become an increasingly dynamic sphere of activity for the firm. Head of litigation Mattson “keeps his clients’ interests at the forefront of his mind and looks for ways to end disputes through negotiation. There’s no arrogance with Rob – he’s a great leader who nurtures talent and creates a good atmosphere around a litigation”. “Eric has been doing some fantastic work for major players in the automotive sector and stands out as far as up-and-coming ITC attorneys are concerned. He looks for a decision on the merits and litigates the right way.” As a team, Mattson and Schweibenz have tasted success against Intellectual Ventures recently, representing leading automotive component company Aisin Seiki. Alexander Hadjis is another trial attorney in his prime who knows what it takes to win in district courts, the PTAB and the ITC. These young guns benefit immeasurably from the backing of senior partner Arthur Neustadt, a veteran litigator and founding member of the firm.

Paul Hastings LLP

Winner of the US Post-grant Firm of the Year award at the inaugural Global IP Awards, Paul Hastings is the cream of the crop when it comes to inter partes reviews and other PTAB proceedings. Standing tall as one of the top patent minds in the United States, Naveen Modi has taken this practice to the highest of heights and garnered wide acclaim in the process: “Naveen is an encyclopaedia of patent law and the most detail-oriented lawyer you could ever work with. Absolutely selfless, he won’t leave the office until everyone is done and is a fantastic role model in his firm and the wider profession.” “His approach is extremely measured, and he never loses his cool.” His recent successes are many for clients including Samsung and Google, but invalidating all claims in a patent covering the most widely used indication for AbbVie’s Humira drug acting on behalf of Boehringer Ingelheim is a particularly juicy result; it gives his client a strong platform for attacking other AbbVie patents. Modi is a must if you want to save on litigation costs and minimise litigation risk; Zimmer Biomet Holdings knows this well, following a fantastic inter partes review result invalidating all 15 claims that Four Mile Bay asserted against it in a district court action. A constant collaborator with Modi, Joseph Palys is also a linchpin of the practice; he knows the ins and outs of the USPTO and district court and Federal Circuit litigation, making him ideally placed for complex PTAB matters. There is no shortage of heavy hitters at Paul Hastings; in many cases for Samsung, trial lawyer Allan Soobert has paved the way for various post-grant successes. Comfortable in the limelight, Soobert is currently acting for the Korean chaebol in a high-profile case against Elm 3DS targeting Samsung’s three-dimensional memory chips that has implications for the entire semiconductor industry. A fearless ITC and district court trial lawyer, Blair Jacobs is also anchoring a substantial competitor battle acting for Align Technology against 3Shape across eight separate cases, including two ITC investigations. A team player, Jacobs is coordinating with his California colleagues on this one, which serves to showcase the coast-to-coast depth of the Paul Hastings practice.

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Known for its elegant and finely calibrated strategies for each moment of a case, and for its composure at trial, Paul, Weiss has become one of the United States’ elite patent litigation firms in recent years. It really cemented this status at the start of 2017 when it added post-grant thought leader Steven Baughman in DC – after all, you cannot be a patent litigation leader without a good (or in Baughman’s case brilliant) PTAB practice. Baughman commands immense respect as “an excellent strategist” who is “superb on the technical detail and as up to date on recent developments in the law as it is possible to be”. Currently, he is engaged in cutting-edge work for Amgen in biosimilar litigation and for Edwards Lifesciences in litigation against Boston Scientific; billions are at stake in his matters, which gives some indication as to the level on which he operates. David Ball is one of the trial lawyers who has helped elevate Paul, Weiss to the IAM Patent 1000 US national litigation list this year. As well as playing a key role in the Amgen work, he has recently masterminded victories for Garmin International in a testy dispute with competitor Navico.

Perkins Coie LLP 

There are lots of exciting things happening in Perkins Coie’s sterling national life sciences practice, from prosecuting patent applications relating to CRISPR/Cas9 gene editing systems to litigating global challenges to patents covering the products of its clients’ competitors. The DC office happens to be home to one of the firm’s best pharmaceutical and biotechnology litigators, Shannon Bloodworth, who became co-chair of the firmwide IP practice in January 2018. “A no-nonsense, highly intelligent and articulate litigator who is excellent on her feet at trial, Shannon is absolutely fantastic.” In July 2018 she hit the headlines with her win for Mylan against the Saint Regis Mohawk, in which the Federal Circuit ruled that Allergan and the tribe cannot use tribal immunity to shield patents on the product Restasis from inter partes review challenges. She is also acting for Mylan to challenge patents covering the next generation of Teva’s Copaxone product, with prior related wins giving her an excellent platform for further success.

Pillsbury Winthrop Shaw Pittman LLP

Pillsbury is a growing force in US patent litigation, thanks particularly to the dynamism being shown by its ITC and ANDA practices. Taking the lead on Section 337 investigations – and making her debut in the IAM Patent 1000 this year – Kecia Reynolds has recently won invalidity and non-infringement determinations for Black & Decker and a host of other respondents, which are of major commercial significance to the companies involved. A seasoned pro who has handled more than 50 investigations, she certainly knows her way around the commission. Keeto Sabharwal is the tip of the spear for pharmaceutical clients in their battles against competitors. An artful persuader in the toughest cases, whatever the technical subject matter involved and whatever the forum, William Atkins is the firm’s best-known IP trial lawyer. A thought leader on patent litigation strategy and post-grant proceedings, he is the chief editor of two treatises on the subjects published by Bloomberg BNA. He is all about teamwork and sets up trial teams that stay the course in litigation – his people don’t drop in and out of cases. Atkins often links up with Jack Barufka to talk tactics; it’s a wise move – Barufka is an excellent sounding board given the comprehensiveness of his patent expertise. Clients call on him for all manner of issues because he knows their daily business and how they like to operate; he fills the trusted adviser role to perfection for UBS and many other prestigious names.

Quinn Emanuel Urquhart & Sullivan LLP

Quinn Emanuel is a natural fit for ITC litigation; it has the requisite resources and is at its best litigating under intense pressure. The firm stays well on top of the commission’s jurisprudence and the mindset of its decision makers thanks to a dedicated Section 337 investigations group chaired by DC-based Alex Lasher. An award-winning veteran of over 60 investigations, Lasher fights the corner of industry leaders such as Qualcomm and Sony.

Rothwell, Figg, Ernst & Manbeck, PC

“An excellent litigation firm that practices with the utmost integrity” is the verdict on DC boutique Rothwell Figg. “Its litigators are deeply and broadly knowledgeable, they think strategically and are excellent at communicating with their clients on the progress of their cases. They are also very mindful of controlling costs.” Trial lawyers do not come better than Steven Lieberman, an “extremely aggressive advocate but one who never crosses the line”. He manages a colossal workload without ever dropping the ball on his cases; lately, he has secured several favourable decisions under Section 101 for Fandango and got a case filed by Moving Media Nordic against his client Big Ten Networks dismissed for no payment or licensing agreement. He makes a great team with Sharon Davis, who is cherished by high-tech and pharmaceutical patrons alike for her crystal-clear, to-the-point advocacy. Rothwell Figg has two new faces in the IAM Patent 1000 this year in Steven Weihrouch and Robert Parker, both accomplished litigators. Weihrouch has an ardent following of Japanese companies – he worked in Japan for two years as a foreign attorney – and has lately been representing leading LED manufacturer Nichia in a slew of litigations against competitors including Feit Electric and Vizio. Parker “understands his clients’ business needs and looks for solutions to complex international disputes that align with them”. “He is incredibly knowledgeable and experienced, and represents with zeal.” He was in on the Nichia action, as was Martin Zoltick, who has much to offer in the form of litigation, post-grant and prosecution expertise and thought leadership on emerging technology areas such as blockchain. Also worthy of special mention are the firm’s outstanding life sciences litigation and post-grant proceedings practices. With pioneer Anthony Figg on deck, the set is steeped in Hatch-Waxman Act litigation like few others, though it has also been making a strong push with respect to biologic drug and biosimilar matters; Figg and Joseph Hynds, a star of both the aforementioned practices, have recently filed numerous inter partes review petitions for biosimilar drug developer Coherus BioSciences. Danny Huntington is another repository of trust for biotechnology and pharmaceutical companies and much respected in the post-grant world thanks to his interference expertise, which he continues to build on; his work highlights include securing a finding of no interference in fact for EDITAS Medicine, a licensee of the Broad Institute, in a matter involving CRISPR gene editing.

Steptoe & Johnson LLP

Steptoe is best known for its patent litigation proficiency, but it is DC-based prosecution pro Harold Fox who gets some of the best feedback. One source comments: “Harold has been by far the most effective patent attorney that I have ever worked with. None of the patent applications he has written have been rejected by the USPTO – Harold is consistently successful in overcoming any adverse arguments made by patent examiners. He and Steptoe have been instrumental in designing our entire patent agenda, considering weaknesses in existing patents in the field and the best strategies to block competitors going down their best paths. Harold is excellent at working with investors and conveying the strength of a portfolio in a way that greatly helps with fundraising.” Confirming this, another says: “He is excellent from both a legal and business perspective.” Fox is primary outside IP counsel for the Massachusetts Institute of Technology and works with many distinguished members of its faculty. Developments on the litigation front include reinforcement of the firm’s much-respected ITC practice. This is helmed by John Caracappa who, unlike many other trial lawyers of his stature, likes to get hands on with his cases. He knows what does and doesn’t work at the commission as a result of experience in more than 75 Section 337 investigations. Putting the firm in a strong position with respect to the market’s increasing tendency towards trade secret litigation is IP and antitrust buff Boyd Cloern. He also makes a strong contribution on ITC campaigns and is currently representing Broadcom in a six-patent matter alongside Caracappa.

Sterne, Kessler, Goldstein & Fox PLLC 

Prosecution continues to be the bedrock of Sterne Kessler’s noble patent service – the trappings that come with its increasingly potent litigation and appellate practice and excellent post-grant offering haven’t prompted a course correction as has been seen with others. Companies seeking to procure patents are placing a premium on efficiency, cost-effectiveness and responsiveness, and chair of prosecution Eric Steffe et al delivers resoundingly on all these thanks to well-calibrated workflow management tools and a client-service mentality. Biotechnology is one of Steffe’s focuses and a bastion of strength for the wider organisation, a founding partner of which is industry trailblazer Jorge Goldstein. The electronics group is stacked, too, and includes firm managing director and strategic counsellor par excellence Michael Ray, foreign filing maestro Donald Featherstone, certified licensing professional Michael Lee and Taiwan Semiconductor Manufacturing Company go-to Robert Sokohl. Sokohl’s practice has lately developed in interesting ways, which have served to underline his impressive versatility as a patent lawyer; he is currently lead counsel on a substantial number of covered business method review proceedings at the PTAB and Federal Circuit appeals. Sterne Kessler is famous for its post-grant expertise, the main founts of which are “excellent strategic thinker and team player” Eldora Ellison and Robert Greene Sterne. “Eldora is deeply skilled in both law and science, and highly adept at obtaining commercially meaningful patents and leading inter partes review teams.” She has put in several exceptional PTAB performances on behalf of Thermo Fisher Scientific recently. An international all-round IP visionary, Sterne has published extensively on PTAB litigation. The firm is also increasingly known for its Federal Circuit prowess not just in relation to post-grant cases but also district court and ITC litigation; Jon Wright and Michael Joffre are doing a fantastic job as co-chairs of the appellate practice. Meaty cases come their way because the firm’s litigators, including John Christopher Rozendaal and Dennies Varughese, are in hot demand when the chips are down. Rozendaal litigates in all technical areas with aplomb – he is very much in the trial lawyer mould and can weave a compelling narrative around any technology. Varughese is the same, though he has a heavy concentration of commercially significant pharmaceutical cases on his docket. Under the leadership of Daniel Yonan, the set’s ITC practice has exploded in recent years as word has spread of its technical expertise combined with its aggressive approach to securing quick resolutions. “Daniel is highly organised and keeps his clients up to date on their cases; he provides detailed budgets and always comes well within them. He also has an expert knowledge of the judges at the ITC.” One other prominent practice to cover is designs; here, Sterne Kessler is a market leader thanks to global design protector, enforcer and strategist Tracy-Gene Durkin – a genius on graphical user interfaces.

Sughrue Mion PLLC

Abundant technical expertise in all scientific and engineering disciplines, a large team of patent specialists, decades of litigation and post-grant experience and international expertise – these are the things that distinguish DC boutique Sughrue Mion. For a key contact, look to Alan Kasper, the director of the firm’s international department. He is wise to the impact that key patent law and policy developments have on patent strategy in the commercial environment.

Venable LLP

The merger of Fitzpatrick attorneys into Venable in August 2018 created one of the largest and best-rounded IP groups in the United States. In DC, the move bolstered several already high-calibre practices: Brian Klock adds litigation and prosecution savvy; Edmund Haughey brings broad IP litigation experience; and Justin Oliver comes with an outstanding post-grant skill set. All three have worked closely with Canon over many years and therefore know how to keep an industry leader happy. Merger news aside, Venable has been hustling and bustling on all fronts. In litigation, the firm has multiple ITC cases on the go right now, which is giving Section 337 investigations specialist Adam Hess and others plenty to be cracking on with. Always in high demand for their trial skills, Frank Cimino and Megan Woodworth have continued to garner success; for example, they obtained a judgment of non-infringement for Verizon in an Eastern District of Texas case against Barkan Wireless Access Technologies which was upheld on appeal. Together with IP chair and veteran high-stakes litigator William Coston, they also secured an eve-of-trial settlement for Viveve Medical against ThermiGen, ThermiAesthetics and Dr Red Alinsod, under which Viveve received a monetary payment for past activity and an ongoing royalty. The team also handles IP procurement and other matters for Viveve, with Michele Van Patten Frank playing a key role in this regard. Best described as a “superior patent strategist”, Frank leverages transactional, litigation and prosecution expertise to deliver holistic counsel. “Michele is a delightfully savvy patent attorney and medical technology industry veteran. She is remarkably skilled in worldwide prosecution and consistently provides creative, business-minded advice. With billing fairness and clarity, cost-efficiency, responsiveness and quality of work in mind, Michele is at the top of her class.” Though it doesn’t seek to hog the limelight, Venable’s dedicated IP transactions practice is deserving of it. Nora Garrote has recently been displaying the deftest of touches in negotiating software-as-a-service and cloud computing agreements; she also has a big smart vehicle technology project on the go. William Russell has acted for General Electric on multiple cross-border deals this past year, including patent licence agreements, global distribution arrangements and joint ventures.

Weil Gotshal & Manges LLP 

Weil has a tradition of excellence in patent litigation and is consistently selected by top technology and life sciences companies to handle their most impactful competitor cases. The firm is quick to deploy tailor-made trial teams, staffed from across its offices, wherever they are needed. DC-based co-head of the national patent litigation practice Brian Ferguson has been working with New York lawyers Anish Desai and global litigation chair David Lender to represent two General Electric divisions in major patent litigation relating to turbine technology; one case involves representing GE Aviation as lead counsel in no less than 31 inter partes review petitions, highlighting how well qualified Weil is to handle PTAB matters.

White & Case LLP

White & Case is punching above its weight in numbers at the PTAB; measured by the number of its filings and its success through final written decisions, the firm is excelling in inter partes reviews. A natural fit for post-issuance proceedings, David Tennant has recently been making his extensive prosecution and litigation experience count for GlobalFoundries in numerous successful petitions arising out of a suit brought by Good Kaisha IP Bridge 1. Tennant brings great teams together to carve out victories and often leans on trial lawyer Shamita Etienne-Cummings, as is the case with GlobalFoundries. Etienne-Cummings continues to keep up appearances at the ITC but has recently been building on her strong trade secret litigation experience.

Williams & Connolly LLP 

Williams & Connolly has an exceptional line-up of trial lawyers with significant first-chair experience who are in their 40s and 50s; they aren’t the types who parachute in at the last minute but are hands on from beginning to end, making important strategic decisions along the journey. One of the best examples of this is Adam Perlman, who is “one of the finest trial counsels in the country”. “Inside and outside the courtroom, he sees the entire battlefield.” When it comes to pharmaceutical cases, he and Bruce Genderson perform flawlessly: “They are extremely thorough in their analysis of the risks and opportunities presented by each case. Likeable and trustworthy people, they make witnesses feel comfortable in situations that ordinarily make them anxious.” Of late, they have been representing Eli Lilly in a number of cases against generic drug manufacturers challenging a patent protecting their client’s blockbuster anti-cancer drug Alimta. Spearheading the set’s fast-growing biologics patent litigation practice, meanwhile, are David Berl and Jessamyn Berniker, two “thoughtful, proactive, experienced, thoroughly prepared and strategically sophisticated lawyers who are effective in any forum”. Away from the life sciences, they have recently paired up to act for Petroleum Geo-Services in several inter partes reviews. Patent licensing disputes have become a real strong suit of Williams & Connolly and the names to note here are Thomas Selby, Kevin Hardy and Jonathan Landy. Selby is an even-keeled, cerebral lawyer who doesn’t get flustered in complex life sciences and high-technology cases; Hardy stands out for his antitrust and IP expertise and knowledge of SEPs; Landy is one of the best in the business of international arbitration.

Wilmer Cutler Pickering Hale and Dorr LLP

With its tremendously successful litigation group working harmoniously with its patent office team, “WilmerHale can handle complex PTAB cases very effectively”. Further, as a result of the leadership shown by David Cavanaugh, the firm is at the cutting edge of developments in post-grant practice and has a fine-grained understanding of their impact on broader IP strategy. In the opinion of his peers, Cavanaugh is exceptional: “Tactically brilliant and thoughtful, when he speaks, people listen. He is incredibly smart, has excellent business judgement and takes a low-key, sensible approach to his work.” WilmerHale also derives a sharp competitive edge in district court litigation and PTAB proceedings from the strength of its superb appellate practice, which is anchored by former US solicitor general Seth Waxman. The picture is no less impressive when you look at the outfit’s ITC activities; an inveterate winner at the commission, Nina Tallon is “highly organised and has great courtroom presence. She is brilliant at handling witnesses”. Active in district courts and the ITC, like Tallon, William McElwain is another of the DC contingent’s vastly capable litigators comfortable with all kinds of technical subject matter.

Winston & Strawn LLP 

“Winston & Strawn’s ITC group is incredibly strong – Thomas Jarvis, Steven Anzalone and Paul Goulet are all top lawyers who have great technical expertise and are steeped in Section 337 practice.” They have been working together for two decades and play off each other’s strengths: Jarvis brings leadership skills to the table and unbeatable knowledge of how the government, trade associations and private enterprises in China respond to patent cases in the ITC; Anzalone is often called on for textbook-worthy cross-examinations of well-known technology experts; Goulet is as knowledgeable as they come on procedural and economic issues and, specifically, the domestic industry requirement. A jewel in the crown of Winston’s glittering nationwide trial practice is its pharmaceutical offering, some of the most important contributions to which come from DC’s Charles Klein, the co-chair of the firmwide IP group and a “top-quality lawyer who is super responsive to his clients”. He has been on a rocket ride lately, obtaining a major victory for Amneal Pharmaceuticals, Apotex, Panacea Biotec, Sun Pharma and Teva at the Federal Circuit and a PTAB ruling which, following Winston’s inter partes review petitions, determined that all claims of two patents on Eli Lilly’s anti-platelet drug Effient were unpatentable as obvious; he also secured a Federal Circuit affirmance of a trial victory for Teva and Hikman against Acorda Therapeutics with respect to the latter’s Amprya multiple sclerosis drug. Another leader in the firm is Andrew Sommer who takes the reins of the post-grant practice.

Xsensus LLP

Xsensus is a new name in the IAM Patent 1000 firm rankings this year; rooted in electrical patent prosecution but already expanding into other technical fields, the patent boutique is creating considerable buzz by leveraging the latest technology to ensure the utmost efficiency on all administrative tasks associated with patent procurement. This is giving Bradley Lytle et al more time to guide clients strategically while also decreasing costs for them. Oblon’s former managing partner, Lytle is transparent, collaborative, forward thinking and internationally minded – making him a vital ally at a time of great change in the patent market.

Other recommended experts

Akin Gump’s Cono Carrano recently secured a significant ITC victory for VIZIO in a complaint filed by Broadcom asserting five decoding and video processing patents against VIZIO and five other respondents. “Cono is really impressive in terms of his business savvy and ability to size up what the decision makers in his cases are all about.” Todd Dickinson has served as chief IP counsel at two Fortune 50 companies and is a former USPTO director; the strategic oversight he can provide to his Polsinelli colleagues and clients is priceless. Passionate about technological innovation, Michael P Dilworth is hailed as a strategist who has cracked the code of IP protection and value creation. The former chief IP counsel has exceptional business judgement. Greg H Gardella is a post-grant thought leader and the founder of Gardella Grace, a patent and trade secret boutique focused on procurement, licensing and enforcement. Clients choose him to defend rights that are foundational to their entire businesses. King & Spalding has made serious moves in the patent market of late, hiring top litigators out of Paul Hastings and Cooley. The addition of ex-Sterne Kessler partner Lori Gordon in DC, however, was one of its most strategically savvy plays; Gordon is a post-grant doyenne who gives the firm immediate credibility as an inter partes review practice. Former Oblon partner Kirsten A Grüneberg set up Grüneberg and Myers to provide a more personalised, quality-focused and reasonably priced service and corporate counsel have reacted enthusiastically. Acting for an enviable European client base, she does everything up to court litigation but is best known as a strategic counsellor. Biochemistry and biophysics PhD Christopher Jeffers leads a well-rounded life sciences team at Mintz. Deep sector knowledge makes him an effective negotiator of IP-driven commercial transactions. Helping to make Orrick a patent litigation force are Sten Jensen and Steven Routh in DC. Jensen is much respected in ITC circles and a former ITC Trial Lawyers Association executive committee member; a fellow of the American College of Trial Lawyers, Routh acquits himself with distinction in district court and ITC litigation and has an ardent following of Japanese clients. High-end corporate firm Bass, Berry & Sims has earmarked intellectual property as a strategic growth area and brought computer scientist Michael Kiklis on board to give it some serious oomph in the patent litigation and post-grant areas. Kiklis is riding high, coming off representing Schlumberger against Halliburton Energy Services in 24 related inter partes reviews – one of the largest such groups the PTAB has ever seen. Former deputy commissioner for patent examination policy, Stephen Kunin has the most intricate knowledge of the USPTO’s workings and is therefore in demand as a testifying expert at trial. He joined patent all-rounders Christopher Maier and Timothy Maier’s eponymous boutique in July 2018. Recommended for their “direct and practical approach, business-mindedness and tremendous hustle”, the two Maiers debut in the IAM Patent 1000 this year. “Scott McKeown has a complete command of post-grant proceedings – he knows the PTAB judges and how to run cases with exceptional efficiency.” Since joining Ropes & Gray in the summer of 2017, he has been extremely busy representing TiVo in many inter partes review petitions filed by Comcast. Flying the flag for Haynes and Boone’s high-calibre prosecution and litigation practices respectively are Jeffrey Wolfson and Kyle Musgrove. A “client-oriented, commercially smart lawyer with a sense of urgency”, Wolfson counsels industry leaders such as offshore drilling company Nabors on IP prosecution and transactional matters. Exceptionally knowledgeable regarding the life sciences industry, Musgrove is the calm at the centre of many a pharmaceutical litigation storm. As a high-powered patent litigation firm, Sidley can often be seen in the ITC; Brian Nester is its leading specialist in the forum. His colleague Carter Phillips needs no introduction – he is one of the country’s top Supreme Court and appellate advocates. Alston & Bird trial lawyer Scott Pivnick got a great win for Coca-Cola at the Federal Circuit which affirmed a Northern District of Georgia ruling that all four patents asserted against Coca-Cola by Automated Tracking Solutions were invalid on subject-matter ineligibility grounds. Perry Saidman of Saidman DesignLaw Group is one of the world’s leading authorities on design patents. Jason M Shapiro of Edell Shapiro & Finnan is a prosecutor, opinion giver, transactions counsel and all-round patent strategist. Clients love the direct and commercial nature of his advice. Smith Baluch partner Matthew Smith has two engineering degrees – electrical and geological – and is the author of a post-grant treatise, an experienced lecturer, fluent German speaker and Federal Circuit litigator. Sean Trainor has enjoyed recent success at the ITC acting for Samsung Electronics against Tessera Advanced Technologies. For this he linked up with lead partner Ryan Yagura and a large and impressive crew of other seasoned litigators at his firm O’Melveny & Myers. Practising out of top West Coast boutique Knobbe Martens, William Zimmerman litigates over some of the most valuable pharmaceutical products day in, day out. The vastly experienced lead counsel recently went to bat for Illumina Cambridge, successfully defending in two inter partes reviews against Complete Genomics.

Individuals: litigation

  • David Berl - Williams & Connolly LLP
  • G Brian Busey - Morrison & Foerster LLP
  • Ruffin B Cordell - Fish & Richardson
  • Edward C Donovan - Kirkland & Ellis LLP
  • Alan M Fisch - Fisch Sigler LLP
  • Bruce R Genderson - Williams & Connolly LLP
  • Maximilian A Grant - Latham & Watkins LLP
  • Gary M Hnath - Mayer Brown
  • J Michael Jakes - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Thomas L Jarvis - Winston & Strawn LLP
  • Steven Lieberman - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles E Lipsey - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Gregg F LoCascio - Kirkland & Ellis LLP
  • Michael McKeon - Fish & Richardson
  • Naveen Modi - Paul Hastings LLP
  • Michael A Morin - Latham & Watkins LLP
  • George F Pappas - Covington & Burling LLP
  • Adam L Perlman - Williams & Connolly LLP
  • Mark A Perry - Gibson Dunn & Crutcher LLP
  • Carter G Phillips - Sidley Austin LLP
  • Bert C Reiser - Latham & Watkins LLP
  • Matthew M Wolf - Arnold & Porter Kaye Scholer LLP
  • V James Adduci II - Adduci, Mastriani & Schaumberg, LLP
  • Steven Anzalone - Winston & Strawn LLP
  • William P Atkins - Pillsbury Winthrop Shaw Pittman LLP
  • David J Ball Jr - Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • James R Barney - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Steven Baughman - Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • Jamie B Beaber - Mayer Brown
  • Shannon Bloodworth - Perkins Coie LLP
  • Paul F Brinkman - Kirkland & Ellis LLP
  • Smith R Brittingham - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • John Caracappa - Steptoe & Johnson LLP
  • Cono A Carrano - Akin Gump Strauss Hauer & Feld LLP
  • Gregory A Castanias - Jones Day
  • Christian Chu - Fish & Richardson
  • Frank C Cimino Jr - Venable LLP
  • Joseph V Colaianni - Fish & Richardson
  • Kevin B Collins - Covington & Burling LLP
  • Mark G Davis - Goodwin Procter LLP
  • Sharon Davis - Rothwell, Figg, Ernst & Manbeck, PC
  • Erin M Dunston - Buchanan Ingersoll & Rooney PC
  • Tracy-Gene G Durkin - Sterne, Kessler, Goldstein & Fox PLLC
  • Eldora L Ellison - Sterne, Kessler, Goldstein & Fox PLLC
  • Brian E Ferguson - Weil Gotshal & Manges LLP
  • David P Frazier - Latham & Watkins LLP
  • Lori A Gordon - King & Spalding LLP
  • Lawrence J Gotts - Latham & Watkins LLP
  • Paul Goulet - Winston & Strawn LLP
  • Alexander J Hadjis - Oblon
  • Kevin Hardy - Williams & Connolly LLP
  • James Heintz - DLA Piper LLP (US)
  • Doris Johnson Hines - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Mark L Hogge - Dentons US LLP
  • Joseph A Hynds - Rothwell, Figg, Ernst & Manbeck, PC
  • Blair M Jacobs - Paul Hastings LLP
  • William G James II - Goodwin Procter LLP
  • William M Jay - Goodwin Procter LLP
  • Robert Katz - Banner Witcoff 
  • Charles B Klein - Winston & Strawn LLP
  • Jonathan M Landy - Williams & Connolly LLP
  • Joseph Lavelle - DLA Piper LLP (US)
  • Louis S Mastriani - Adduci, Mastriani & Schaumberg, LLP
  • William G McElwain - Wilmer Cutler Pickering Hale and Dorr LLP
  • James Monroe - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Matthew J Moore - Latham & Watkins LLP
  • Brian Nester - Sidley Austin LLP
  • John O'Quinn - Kirkland & Ellis LLP
  • Ronald Pabis - Goodwin Procter LLP
  • Richard Rainey - Covington & Burling LLP
  • Jay H Reiziss - McDermott Will & Emery
  • Timothy W Riffe - Fish & Richardson
  • Steven J Routh - Orrick, Herrington & Sutcliffe LLP
  • John Christopher Rozendaal - Sterne, Kessler, Goldstein & Fox PLLC
  • Tom M Schaumberg - Adduci, Mastriani & Schaumberg, LLP
  • Thomas HL Selby - Williams & Connolly LLP
  • Sturgis Sobin - Covington & Burling LLP
  • Allan M Soobert - Paul Hastings LLP
  • Robert Steinberg - Latham & Watkins LLP
  • Thomas P Steindler - McDermott Will & Emery
  • Robert Greene Sterne - Sterne, Kessler, Goldstein & Fox PLLC
  • Einar Stole - Covington & Burling LLP
  • Nina S Tallon - Wilmer Cutler Pickering Hale and Dorr LLP
  • Seth P Waxman - Wilmer Cutler Pickering Hale and Dorr LLP
  • William Zimmerman - Knobbe Martens
  • Pavan K Agarwal - Foley & Lardner LLP
  • Stephen Baskin - Mayer Brown
  • William Bergmann - Baker & Hostetler LLP
  • Jeffrey A Berkowitz - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Jessamyn S Berniker - Williams & Connolly LLP
  • Brian M Buroker - Gibson Dunn & Crutcher LLP
  • Alexander Chinoy - Covington & Burling LLP
  • Boyd Cloern - Steptoe & Johnson LLP
  • William D Coston - Venable LLP
  • Ahmed Davis - Fish & Richardson
  • Lauren Degnan - Fish & Richardson
  • Dipu A Doshi - Blank Rome LLP
  • Tara D Elliott - Latham & Watkins LLP
  • Shamita D Etienne-Cummings - White & Case LLP
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael J Flibbert - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michele Van Patten Frank - Venable LLP
  • Blaney Harper - Jones Day
  • Edmund J Haughey III - Venable LLP
  • Adam R Hess - Venable LLP
  • John R Hutchins - Banner Witcoff 
  • Nicole M Jantzi - McDermott Will & Emery
  • Sten A Jensen - Orrick, Herrington & Sutcliffe LLP
  • Michael E Joffre - Sterne, Kessler, Goldstein & Fox PLLC
  • Song K Jung - Dentons US LLP
  • Lisa Kattan - Baker Botts LLP
  • Michael L Kiklis - Bass, Berry & Sims PLC
  • Alex Lasher - Quinn Emanuel Urquhart & Sullivan LLP
  • Robert Mattson - Oblon
  • Patrick J McCarthy - Goodwin Procter LLP
  • Erik Milch - Cooley LLP
  • Indranil Mukerji - Fish & Richardson
  • Kyle Musgrove - Haynes and Boone LLP
  • Eric Namrow - Morgan Lewis & Bockius LLP
  • Joseph E Palys - Paul Hastings LLP
  • Robert Parker - Rothwell, Figg, Ernst & Manbeck, PC
  • Douglas H Pearson - Jones Day
  • Luke K Pedersen - Baker Botts LLP
  • Frank Pietrantonio - Cooley LLP
  • Scott J Pivnick - Alston & Bird LLP
  • Kecia J Reynolds - Pillsbury Winthrop Shaw Pittman LLP
  • H Keeto Sabharwal - Pillsbury Winthrop Shaw Pittman LLP
  • Paul Schoenhard - McDermott Will & Emery
  • Stephen T Schreiner - Goodwin Procter LLP
  • Eric W Schweibenz - Oblon
  • Stephen Shahida - Goodwin Procter LLP
  • Christopher N Sipes - Covington & Burling LLP
  • Matthew A Smith - Smith Baluch LLP
  • S Lloyd Smith - Buchanan Ingersoll & Rooney PC
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Andrew Sommer - Winston & Strawn LLP
  • Sanya Sukduang - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • D Sean Trainor - O’Melveny & Myers LLP
  • Jamie Underwood - Latham & Watkins LLP
  • Dennies Varughese - Sterne, Kessler, Goldstein & Fox PLLC
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Megan S Woodworth - Venable LLP
  • Jon E Wright - Sterne, Kessler, Goldstein & Fox PLLC
  • Daniel E Yonan - Sterne, Kessler, Goldstein & Fox PLLC
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: prosecution

  • Erika Harmon Arner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Courtenay Brinckerhoff - Foley & Lardner LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Tracy-Gene G Durkin - Sterne, Kessler, Goldstein & Fox PLLC
  • Greg H Gardella - Gardella Grace PA 
  • Jorge Goldstein - Sterne, Kessler, Goldstein & Fox PLLC
  • John F Hayden - Fish & Richardson
  • R Danny Huntington - Rothwell, Figg, Ernst & Manbeck, PC
  • Thomas L Irving - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Song K Jung - Dentons US LLP
  • Stephen G Kunin - Maier & Maier PLLC
  • Michael Q Lee - Sterne, Kessler, Goldstein & Fox PLLC
  • David R Marsh - Arnold & Porter Kaye Scholer LLP
  • Scott A McKeown - Ropes & Gray LLP
  • Mercedes K Meyer - Drinker Biddle & Reath LLP
  • W Karl Renner - Fish & Richardson
  • Michael Sartori - Baker Botts LLP
  • Mark D Sweet - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Ping Wang - Morris Manning & Martin LLP
  • Christopher Agrawal - Bookoff McAndrews PLLC
  • MaryAnne Armstrong - Birch, Stewart, Kolasch & Birch, LLP
  • W Todd Baker - Oblon
  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • Les Bookoff - Bookoff McAndrews PLLC
  • James W Brady Jr - Blank Rome LLP
  • Martin A Bruehs - Dentons US LLP
  • Adriana L Burgy - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Ross A Dannenberg - Banner Witcoff 
  • Michael P Dilworth - Dilworth IP 
  • Bryan C Diner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Donald J Featherstone - Sterne, Kessler, Goldstein & Fox PLLC
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Thomas Fiala - Fiala & Weaver PLLC 
  • Michael E Fogarty - McDermott Will & Emery
  • Harold H Fox - Steptoe & Johnson LLP
  • Michele Van Patten Frank - Venable LLP
  • C Gregory Gramenopoulos - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Kirsten A Grüneberg - Grüneberg and Myers PLLC 
  • Robert L Hails Jr - Baker & Hostetler LLP
  • John Harrity - Harrity & Harrity LLP
  • Paul Harrity - Harrity & Harrity LLP
  • David L Holt - Fish & Richardson
  • Kirsten Johnson - Bookoff McAndrews PLLC
  • Susanne T Jones - Jones Robb PLLC
  • David EA Jordan - Fish & Richardson
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Brian L Klock - Venable LLP
  • Mark R Kresloff - Dentons US LLP
  • Phyllis K Kristal - Fish & Richardson
  • Dale Lazar - DLA Piper LLP (US)
  • Hosang Lee - Morgan Lewis & Bockius LLP
  • Bradley Lytle - Xsensus LLP
  • Stephen B Maebius - Foley & Lardner LLP
  • Christopher Maier - Maier & Maier PLLC
  • Timothy J Maier - Maier & Maier PLLC
  • Roland G McAndrews - Bookoff McAndrews PLLC
  • Frederic M Meeker - Banner Witcoff 
  • Dinesh N Melwani - Bookoff McAndrews PLLC
  • Erik Milch - Cooley LLP
  • Marina Miller - Oblon
  • Gianni Minutoli - DLA Piper LLP (US)
  • Darrell G Mottley - Banner Witcoff 
  • Robert G Mukai - Buchanan Ingersoll & Rooney PC
  • Shawn W O'Dowd - Hunton Andrews Kurth LLP
  • Justin J Oliver - Venable LLP
  • Luke K Pedersen - Baker Botts LLP
  • George E Quillin - Foley & Lardner LLP
  • Timothy W Riffe - Fish & Richardson
  • Kevin D Robb - Jones Robb PLLC
  • William C Rowland - Buchanan Ingersoll & Rooney PC
  • Daniel G Shanley - Hunton Andrews Kurth LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Kenneth J Sheehan - Baker & Hostetler LLP
  • Vincent K Shier - Oblon
  • Philippe Signore - Oblon
  • Michele Simkin - Foley & Lardner LLP
  • Robert Smyth - Morgan Lewis & Bockius LLP
  • Stephen A Soffen - Blank Rome LLP
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Eric Sophir - Dentons US LLP
  • Eric K Steffe - Sterne, Kessler, Goldstein & Fox PLLC
  • C Scott Talbot - Cooley LLP
  • David M Tennant - White & Case LLP
  • Todd R Walters - Buchanan Ingersoll & Rooney PC
  • Jeffrey S Weaver - Fiala & Weaver PLLC 
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles F Wieland III - Buchanan Ingersoll & Rooney PC
  • Jeffrey A Wolfson - Haynes and Boone LLP
  • Yanbin Xu - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael X Ye - Morris Manning & Martin LLP
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: transactions

  • Michael Q Lee - Sterne, Kessler, Goldstein & Fox PLLC
  • John C Paul - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Nora E Garrote - Venable LLP
  • Jorge Goldstein - Sterne, Kessler, Goldstein & Fox PLLC
  • Donald A Gregory - Blank Rome LLP
  • Jon D Grossman - Blank Rome LLP
  • Susan E Hendrickson - Arnold & Porter Kaye Scholer LLP
  • John Hurvitz - Covington & Burling LLP
  • Stuart Irvin - Covington & Burling LLP
  • Christopher E Jeffers - Mintz
  • Song K Jung - Dentons US LLP
  • D Brian Kacedon - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Stephen B Maebius - Foley & Lardner LLP
  • J Derek Mason - Oblon
  • Luke K Pedersen - Baker Botts LLP
  • William H Pratt - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael B Ray - Sterne, Kessler, Goldstein & Fox PLLC
  • William T Russell - Venable LLP
  • Adam Ruttenberg - Cooley LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Robert Greene Sterne - Sterne, Kessler, Goldstein & Fox PLLC
  • David M Tennant - White & Case LLP
  • Ping Wang - Morris Manning & Martin LLP

Luminaries

  • Todd Dickinson - Polsinelli PC
  • Donald R Dunner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • E Anthony Figg - Rothwell, Figg, Ernst & Manbeck, PC
  • Alan M Grimaldi - Mayer Brown
  • Lynn Levine - Morrison & Foerster LLP
  • Arthur I Neustadt - Oblon
  • Perry Saidman - Saidman DesignLaw Group
  • Robert L Stoll - Drinker Biddle & Reath LLP